Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$5.8M
-24.1% from 2023
Prescriptions
1,248
$4,643.08 per claim
Patients
218
268 prescribers
Total spending, 2024
$5.9M
$26,815.08 per patient
Medicare prescription drug plans paid $5.8M for Lapatinib in 2024, for 1,248 prescriptions and refills to 218 patients (down 24.1% from 2023). The average cost per claim was $4,643.08.
California had the highest Medicare cost for Lapatinib in 2024: $686K for 175 claims, followed by Texas ($563K).
Yi-Kong Keung, hematology-oncology in Alhambra, CA, had the highest Medicare cost for Lapatinib in 2024: 12 claims costing $82K.
Lapatinib is made by Lupin Limited (LUPIN.NS), listed in the Medicare spending data as Lupin Pharmaceu.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Yi-Kong Keung Alhambra, CA | Hematology-Oncology | 12 | Under 11 | $82K |
| Sanjay Yadav Columbus, OH | Hematology-Oncology | 12 | Under 11 | $81K |
| Anas A Khanfar |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 299 | 1,503 | 263 | $7.6M |
| 2023 | 302 | 1,536 | 259 | $7.6M |
| 2024 | 268 | 1,248 | 218 | $5.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 12 |
| Under 11 |
| $80K |
| Ajay P Abad Buffalo, NY | Neurology | 12 | Under 11 | $78K |
| Josselyn G Molina Avila Fajardo, PR | Hematology-Oncology | 11 | Under 11 | $78K |
| Zaki A Samman Fort Smith, AR | Hematology-Oncology | 11 | Under 11 | $77K |
| Linnea I Chap Beverly Hills, CA | Medical Oncology | 15 | Under 11 | $76K |
| Ana M Gaviria Plantation, FL | Nurse Practitioner | 11 | Under 11 | $69K |
| Haruka Itakura Stanford, CA | Hematology-Oncology | 13 | Under 11 | $66K |
| Shannon S Serie Nashville, TN | Hematology-Oncology | 13 | Under 11 | $66K |
| Sirisha Karri Dallas, TX | Medical Oncology | 12 | Under 11 | $65K |
| Rebecca Jaslow Voorhees, NJ | Hematology-Oncology | 12 | Under 11 | $65K |
| Chun F Ng Stockton, CA | Hematology-Oncology | 17 | Under 11 | $65K |
| Sumalatha Patibandla Beaumont, TX | Hematology-Oncology | 12 | Under 11 | $64K |
| Thomas C Williamson Jr. Winston Salem, NC | Hematology-Oncology | 12 | Under 11 | $62K |
| Sreenivas V Rao Florence, SC | Hematology-Oncology | 12 | Under 11 | $62K |
| Charlesse P Huannou Springfield, NJ | Hematology-Oncology | 13 | Under 11 | $61K |
| Shahzad A Siddique Carmichael, CA | Hematology-Oncology | 12 | Under 11 | $61K |
| Muhammad Y Hamdan Lansing, MI | Hematology-Oncology | 12 | Under 11 | $60K |
| Louise G Ligresti Paramus, NJ | Medical Oncology | 12 | Under 11 | $56K |
| Shantae L Lucas Asheville, NC | Internal Medicine | 11 | Under 11 | $56K |
| Nikita C Shah Orlando, FL | Hematology-Oncology | 11 | Under 11 | $56K |
| Sandor A Romero Miami, FL | Internal Medicine | 11 | Under 11 | $54K |
| Amna G Khattak Memphis, TN | Hematology-Oncology | 11 | Under 11 | $53K |
| Jennifer Fisher San Diego, CA | Hematology-Oncology | 11 | Under 11 | $51K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Lupin Pharmaceu LUPIN.NS | 1,260 | $5.9M |